| Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer V Chalasani, JL Chin, JI Izawa Canadian Urological Association Journal 3 (6 Suppl 4), S193, 2009 | 272 | 2009 |
| The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the … L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ... European urology 80 (6), 682-689, 2021 | 247 | 2021 |
| Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with … IA Thangasamy, V Chalasani, A Bachmann, HH Woo European urology 62 (2), 315-323, 2012 | 218 | 2012 |
| Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen … L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ... Journal of Nuclear Medicine 60 (7), 950-954, 2019 | 179 | 2019 |
| Use of Clavien-Dindo classification in reporting and grading complications after urological surgical procedures: analysis of 2010 to 2012 PD Yoon, V Chalasani, HH Woo The Journal of urology 190 (4), 1271-1274, 2013 | 150 | 2013 |
| Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and … RJS Calopedos, V Chalasani, R Asher, L Emmett, HH Woo Prostate Cancer and Prostatic Diseases 20 (3), 352-360, 2017 | 88 | 2017 |
| Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full‐text journal articles PD Yoon, V Chalasani, HH Woo BJU international 110 (4), 485-489, 2012 | 68 | 2012 |
| Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen … A Amin, A Blazevski, J Thompson, MJ Scheltema, MS Hofman, D Murphy, ... BJU international 125 (4), 515-524, 2020 | 65 | 2020 |
| Intravesical chemotherapy plus bacille C almette‐G uérin in non‐muscle invasive bladder cancer: a systematic review with meta‐analysis BB Houghton, V Chalasani, D Hayne, P Grimison, CSB Brown, MI Patel, ... BJU international 111 (6), 977-983, 2013 | 65 | 2013 |
| Whole‐gland salvage high‐intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy H Uddin Ahmed, P Cathcart, V Chalasani, A Williams, N McCartan, ... Cancer 118 (12), 3071-3078, 2012 | 62 | 2012 |
| Systematic review and meta-analysis on management of acute urinary retention PD Yoon, V Chalasani, HH Woo Prostate Cancer and Prostatic Diseases 18 (4), 297-302, 2015 | 59 | 2015 |
| An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? E Feletto, A Bang, D Cole-Clark, V Chalasani, K Rasiah, DP Smith World journal of urology 33, 1677-1687, 2015 | 55 | 2015 |
| Salvage HIFU for recurrent prostate cancer after radiotherapy V Chalasani, CH Martinez, D Lim, J Chin Prostate cancer and prostatic diseases 12 (2), 124-129, 2009 | 53 | 2009 |
| Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression TD Palmer, CH Martínez, C Vasquez, KE Hebron, C Jones-Paris, ... Cancer research 74 (1), 173-187, 2014 | 51 | 2014 |
| Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180‐W Greenlight lithium triborate laser GL Knapp, V Chalasani, HH Woo BJU international 119, 33-38, 2017 | 42 | 2017 |
| Development and validation of a virtual reality transrectal ultrasound guided prostatic biopsy simulator V Chalasani, DW Cool, S Sherebrin, A Fenster, J Chin, JI Izawa Canadian Urological Association Journal 5 (1), 19, 2011 | 35 | 2011 |
| Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience V Chalasani, W Kassouf, JL Chin, Y Fradet, AG Aprikian, AS Fairey, ... Canadian Urological Association Journal 5 (2), 83, 2011 | 29 | 2011 |
| Cumulative summation graphs are a useful tool for monitoring positive surgical margin rates in robot‐assisted radical prostatectomy AK Williams, V Chalasani, CH Martínez, E Osbourne, L Stitt, JI Izawa, ... BJU international 107 (10), 1648-1652, 2011 | 28 | 2011 |
| Effect of prostate gland size on the learning curve for robot-assisted laparoscopic radical prostatectomy: does size matter initially? CH Martinez, V Chalasani, D Lim, L Nott, RJ Al-Bareeq, GR Wignall, L Stitt, ... Journal of endourology 24 (2), 261-266, 2010 | 28 | 2010 |
| Salvage radiotherapy following radical prostatectomy V Chalasani, AE Iansavichene, M Lock, JI Izawa International journal of urology 16 (1), 31-36, 2009 | 23 | 2009 |
